Human Biospecimens in the Era of Personalized Medicine
Workshop
Wednesday, March 16, 2011 , San Jose, CA
AGENDA
11:30 AM - 12:00 PM Registration, Lunch, & Networking
12:00 PM - 1:00 PM Presentation & Q&A
OVERVIEW
Modern biomedical research requires continuous supply of legally and ethically acquired high quality human biospecimens and associated data. Preservation of pre-analytical biospecimen variables, significantly confounding research of the disease biomarkers and development of modern diagnostics, will be discussed. Other topics include: collection of biospecimens using standard protocols versus custom protocols; effective use of currently available biorepositories for future studies on the indicated subject; relevant regulatory and legal issues, including international disparities in regulations on use of human materials for biomedical research.
Human biospecimens: the foundation of translational medical research
Important pre-analytical aspects of human biospecimen procurement:
tissue collection specifications
processing materials and methods
storage and shipping procedures
analyte preparation techniques
Standard operating procedures:
collection and handling of human biospecimens
legal and ethical considerations
clinical data collection and management
Project-based collection protocols and custom assay development
Effective utilization of human biospecimens in modern biomedical research, including development of new drugs, novel biomarkers and personalized molecular diagnostics
SPEAKER
Olga Potapova, Ph.D., Founder, CEO and Scientific Director, Cureline, Inc.
VENUE
The San Jose BioCenter
5941 Optical Court
San Jose, CA 95138
Click here for venue directions»
SPEAKER BIOS
Olga Potapova is an expert in biotechnology and life sciences business development. Since 2003, Dr. Potapova leads Cureline, the international biomedical project management group of companies working in the areas of human tissue acquisition (www.cureline.com), clinical research consulting (www.CCCPtrials.com), and diagnostics and laboratory services (www.CurelineBioPathology.com). At Cureline, she is responsible for strategic development, international alliance management, new products and services development and expansion into new markets. Previously she worked in the fields of cancer research human molecular genetics and genomics, oncology drug R&D and translational medicine (NIH and Pfizer/SUGEN). Olga has received multiple AACR/AFLAC awards, NIH and NATO fellowships, and has published multiple scientific papers in peer-reviewed journals. Dr. Potapova holds international and US patents, and has advanced degrees in Physics (M.Sc.) and in Molecular Genetics/Biochemistry (Ph.D.).
